Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Clinical trial NCT00118196 · TERMINATED
Trial details
- NCT number
- NCT00118196
- Sponsor
- Medical University of South Carolina
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2006-08-11
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.